This episode explores the future of skin biomarkers. Featuring insights from Simon Grant, CEO of Ascilion, and Théo Boyer, Senior Project Coordinator at Indero, the episode examines how dermal interstitial fluid (d-ISF) could revolutionize dermatology. Our guests illuminate the potential of ISF sampling, paving the way for more personalized and innovative approaches to care.
All content for Phase Forward is the property of Podcast Series hosted by Valerie Coveney and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This episode explores the future of skin biomarkers. Featuring insights from Simon Grant, CEO of Ascilion, and Théo Boyer, Senior Project Coordinator at Indero, the episode examines how dermal interstitial fluid (d-ISF) could revolutionize dermatology. Our guests illuminate the potential of ISF sampling, paving the way for more personalized and innovative approaches to care.
In this episode, we are joined by Harley Skorpenske, a Clinical Research Associate II at Indero, who brings extensive experience in clinical research across various therapeutic areas, particularly dermatology and rheumatology. Harley's innovative approaches to patient recruitment and retention have significantly enhanced the success rates of numerous clinical trials. Together, we explore the optimization of recruitment and retention in Rheumatoid Arthritis (RA) clinical trials, discussing the challenges and considerations in recruiting participants, the impact of seasonal and environmental factors, and proven strategies to enhance recruitment and retention. Tune in to gain valuable insights from Harley's expertise and learn how to overcome common obstacles in RA clinical trials.
Phase Forward
This episode explores the future of skin biomarkers. Featuring insights from Simon Grant, CEO of Ascilion, and Théo Boyer, Senior Project Coordinator at Indero, the episode examines how dermal interstitial fluid (d-ISF) could revolutionize dermatology. Our guests illuminate the potential of ISF sampling, paving the way for more personalized and innovative approaches to care.
